Zacks: Cantel Medical Corp. (NYSE:CMD) Given Average Recommendation of “Buy” by Brokerages

Shares of Cantel Medical Corp. (NYSE:CMD) have been assigned an average broker rating score of 2.33 (Buy) from the three analysts that provide coverage for the stock, Zacks Investment Research reports. Two investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. Cantel Medical’s rating score has improved by 6.8% from 90 days ago as a result of a number of analysts’ ratings changes.

Analysts have set a 1 year consensus target price of $120.00 for the company and are expecting that the company will post $0.61 EPS for the current quarter, according to Zacks. Zacks has also assigned Cantel Medical an industry rank of 84 out of 256 based on the ratings given to its competitors.

Shares of Cantel Medical stock traded down $1.79 during trading hours on Monday, hitting $89.08. The company’s stock had a trading volume of 111,600 shares, compared to its average volume of 270,576. Cantel Medical has a twelve month low of $63.47 and a twelve month high of $99.68. The company’s fifty day simple moving average is $82.86. The company has a market cap of $3.73 billion, a PE ratio of 35.49 and a beta of 1.11. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.45 and a current ratio of 2.33.

Cantel Medical (NYSE:CMD) last posted its earnings results on Tuesday, June 4th. The company reported $0.55 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.55. Cantel Medical had a return on equity of 15.52% and a net margin of 6.95%. The firm had revenue of $228.55 million for the quarter, compared to analyst estimates of $225.95 million. Equities analysts predict that Cantel Medical will post 2.35 earnings per share for the current year.

The company also recently announced a Semi-Annual dividend, which was paid on Wednesday, July 31st. Investors of record on Wednesday, July 17th were paid a dividend of $0.10 per share. The ex-dividend date of this dividend was Tuesday, July 16th. Cantel Medical’s payout ratio is 7.97%.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.

Read More: What is the Rule of 72?

Get a free copy of the Zacks research report on Cantel Medical (CMD)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with's FREE daily email newsletter.